Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine
Rheumatoid arthritis (RA) is an joint autoimmune inflammatory disease characterized by systemic destructive and progressive inflammatory synovitis caused by chemokines, reactive oxygen species, and proinflammatory cytokines produced by neutrophils and macrophages in the synovial membrane. The object...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Sankt-Peterburg : NIIÈM imeni Pastera
2025-04-01
|
| Series: | Инфекция и иммунитет |
| Subjects: | |
| Online Access: | https://iimmun.ru/iimm/article/viewFile/17689/2059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850275991793958912 |
|---|---|
| author | M. P. Kostinov Bairma Ts. Batozhargalova I. V. Bisheva E. A. Kurbatova A. D. Shmitko G. V. Lukina D. A. Murtazalieva S. A. Skhodova D. A. Blagovidov |
| author_facet | M. P. Kostinov Bairma Ts. Batozhargalova I. V. Bisheva E. A. Kurbatova A. D. Shmitko G. V. Lukina D. A. Murtazalieva S. A. Skhodova D. A. Blagovidov |
| author_sort | M. P. Kostinov |
| collection | DOAJ |
| description | Rheumatoid arthritis (RA) is an joint autoimmune inflammatory disease characterized by systemic destructive and progressive inflammatory synovitis caused by chemokines, reactive oxygen species, and proinflammatory cytokines produced by neutrophils and macrophages in the synovial membrane. The objective of the work was to study indicators of leukocyte phagocytic activity and factors of leukocyte oxygen-dependent bactericidal activity in patients with rheumatoid arthritis receiving methotrexate (MTX) and tofacitinib (TOFA), vaccinated with pneumococcal conjugate vaccine (PCV13). Materials and methods. The study included 151 patients with RA (78.1% women and 21.9% men aged 26–69 years). PCV13 vaccination was carried out once in a dose of 0.5 ml intramuscularly in subjects receiving TOFA and MTX; TOFA was initiated 10–14 days after vaccination; those in comparison groups received same drugs. At the time of inclusion in the study, and during control visits 3 months and 12 months later, leukocyte phagocytic activity and NBT test were carried out. Results. Before the study, patients had minor quantitative and functional changes in leukocyte phagocytic activity and a decrease in the reserve capacity of oxygen-dependent bactericidal activity. In PCV13 vaccinated patients receiving TOFA (Group II), a minor decrease in the phagocytic activity of neutrophilic granulocytes was determined. In unvaccinated patients from group V receiving TOFA therapy, an increase in monocyte absorptive activity was observed both 3 months and 12 months later. In PCV13 vaccinated RA patients from group II receiving TOFA, similar changes were noted. Methotrexate therapy in PCV13 vaccinated and unvaccinated patients did not affect leukocyte phagocytic activity. Conclusion. In patients with RA, PCV13 caused a slight decrease in neutrophil absorptive capacity, which was restored one year post-vaccination accompanied by higher leukocyte oxygen-dependent bactericidal activity in the form of ROS production, which helps to strengthen immune defense in patients encountering potential pathogens. |
| format | Article |
| id | doaj-art-515925ec4cce4f6d9ddb05aee4b786dd |
| institution | OA Journals |
| issn | 2220-7619 2313-7398 |
| language | Russian |
| publishDate | 2025-04-01 |
| publisher | Sankt-Peterburg : NIIÈM imeni Pastera |
| record_format | Article |
| series | Инфекция и иммунитет |
| spelling | doaj-art-515925ec4cce4f6d9ddb05aee4b786dd2025-08-20T01:50:27ZrusSankt-Peterburg : NIIÈM imeni PasteraИнфекция и иммунитет2220-76192313-73982025-04-0115110311110.15789/2220-7619-LPA-176891501Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccineM. P. Kostinov0Bairma Ts. Batozhargalova1I. V. Bisheva2E. A. Kurbatova3A. D. Shmitko4G. V. Lukina5D. A. Murtazalieva6S. A. Skhodova7D. A. Blagovidov8I.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraA.S. Loginov Moscow Clinical Scientific CenterA.S. Loginov Moscow Clinical Scientific CenterI.I. Mechnikov Research Institute of Vaccines and SeraI.I. Mechnikov Research Institute of Vaccines and SeraRheumatoid arthritis (RA) is an joint autoimmune inflammatory disease characterized by systemic destructive and progressive inflammatory synovitis caused by chemokines, reactive oxygen species, and proinflammatory cytokines produced by neutrophils and macrophages in the synovial membrane. The objective of the work was to study indicators of leukocyte phagocytic activity and factors of leukocyte oxygen-dependent bactericidal activity in patients with rheumatoid arthritis receiving methotrexate (MTX) and tofacitinib (TOFA), vaccinated with pneumococcal conjugate vaccine (PCV13). Materials and methods. The study included 151 patients with RA (78.1% women and 21.9% men aged 26–69 years). PCV13 vaccination was carried out once in a dose of 0.5 ml intramuscularly in subjects receiving TOFA and MTX; TOFA was initiated 10–14 days after vaccination; those in comparison groups received same drugs. At the time of inclusion in the study, and during control visits 3 months and 12 months later, leukocyte phagocytic activity and NBT test were carried out. Results. Before the study, patients had minor quantitative and functional changes in leukocyte phagocytic activity and a decrease in the reserve capacity of oxygen-dependent bactericidal activity. In PCV13 vaccinated patients receiving TOFA (Group II), a minor decrease in the phagocytic activity of neutrophilic granulocytes was determined. In unvaccinated patients from group V receiving TOFA therapy, an increase in monocyte absorptive activity was observed both 3 months and 12 months later. In PCV13 vaccinated RA patients from group II receiving TOFA, similar changes were noted. Methotrexate therapy in PCV13 vaccinated and unvaccinated patients did not affect leukocyte phagocytic activity. Conclusion. In patients with RA, PCV13 caused a slight decrease in neutrophil absorptive capacity, which was restored one year post-vaccination accompanied by higher leukocyte oxygen-dependent bactericidal activity in the form of ROS production, which helps to strengthen immune defense in patients encountering potential pathogens.https://iimmun.ru/iimm/article/viewFile/17689/2059rheumatoid arthritispcv13methotrexatetofacitinibphagocytic activity of leukocytesnts test |
| spellingShingle | M. P. Kostinov Bairma Ts. Batozhargalova I. V. Bisheva E. A. Kurbatova A. D. Shmitko G. V. Lukina D. A. Murtazalieva S. A. Skhodova D. A. Blagovidov Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine Инфекция и иммунитет rheumatoid arthritis pcv13 methotrexate tofacitinib phagocytic activity of leukocytes nts test |
| title | Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine |
| title_full | Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine |
| title_fullStr | Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine |
| title_full_unstemmed | Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine |
| title_short | Leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine |
| title_sort | leukocyte phagocytic activity in patients with rheumatoid artritis during vaccination with pneumococcal vaccine |
| topic | rheumatoid arthritis pcv13 methotrexate tofacitinib phagocytic activity of leukocytes nts test |
| url | https://iimmun.ru/iimm/article/viewFile/17689/2059 |
| work_keys_str_mv | AT mpkostinov leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT bairmatsbatozhargalova leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT ivbisheva leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT eakurbatova leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT adshmitko leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT gvlukina leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT damurtazalieva leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT saskhodova leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine AT dablagovidov leukocytephagocyticactivityinpatientswithrheumatoidartritisduringvaccinationwithpneumococcalvaccine |